|
Comparing Two Ways to Manage Head and Neck Lymphedema
RECRUITINGN/ASponsored by Abramson Cancer Center at Penn Medicine
Actively Recruiting
PhaseN/A
SponsorAbramson Cancer Center at Penn Medicine
Started2022-03-11
Est. completion2026-11-30
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations6 sites
View on ClinicalTrials.gov →
NCT05182229
Summary
This randomized clinical trial aims to compare clinic-based CDT and home-based (a hybrid model) CDT on changes in the severity of lymphedema, symptom burden, functional status, and healthcare utilization in HNC survivors with lymphedema.
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: * \>18 years of age * \<=24 months post-HNC treatment * Diagnosis of head and neck lymphedema and referral by their oncology providers * Able to perform self-manual lymphatic drainage * Having an electronic device (a computer, tablet, iPad, laptop, or smartphone) and internet access at home Exclusion Criteria: * Active infection in soft tissues in the head and neck region * History of moderate or severe carotid artery occlusion * Significantly severe lymphedema (e.g., severe periorbital swelling) * Conditions impacting the safe delivery of lymphedema therapy
Conditions3
CancerHead and Neck CancerLymphedema
Locations6 sites
Jefferson Cherry Hospital Jefferson Health
Cherry Hill, New Jersey, 08002
University of Pennsylvania
Philadelphia, Pennsylvania, 19104
Jefferson Health
Philadelphia, Pennsylvania, 19107
Jefferson Torresdale Hospital Jefferson Health
Philadelphia, Pennsylvania, 19114
Temple University Hospital and Fox Chase Cancer Center
Philadelphia, Pennsylvania, 19140
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorAbramson Cancer Center at Penn Medicine
Started2022-03-11
Est. completion2026-11-30
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations6 sites
View on ClinicalTrials.gov →
NCT05182229